twenty patients with idiopathic parkinsonism who had been on optimal levodopa therapy for at least 3 months prior to the investigation and where effect of the treatment was decreasing or side effects were increasing , were treated with bromocriptine in a double-blind crossover trial during a 12 + 12 weeks period .
C0030567
idiopathic parkinsonism
C0006230
bromocriptine